| Ident. | Authors (with country if any) | Title |
|---|
| 000131 (2016) |
Jeffrey D. Dellavolpe [États-Unis] ; Jeffrey M. Garavaglia [États-Unis] ; David T. Huang [États-Unis] | Management of Complications of End-Stage Liver Disease in the Intensive Care Unit. |
| 000464 (2015) |
Olga Vriz [Italie] ; Paola Argiento [Italie] ; Michele D'Alto [Italie] ; Francesco Ferrara [Italie] ; Rebecca Vanderpool [États-Unis] ; Robert Naeije [Belgique] ; Eduardo Bossone [Italie] | Increased pulmonary vascular resistance in early stage systemic hypertension: a resting and exercise stress echocardiography study. |
| 000506 (2015) |
Craig H. Reynolds [États-Unis] ; Jyoti D. Patel [États-Unis] ; Edward B. Garon [États-Unis] ; Mark R. Olsen [États-Unis] ; Philip Bonomi [États-Unis] ; Ramaswamy Govindan [États-Unis] ; Eduardo J. Pennella [États-Unis] ; Jingyi Liu [États-Unis] ; Susan C. Guba [États-Unis] ; Shi Li [États-Unis] ; David R. Spigel [États-Unis] ; Robert C. Hermann [États-Unis] ; Mark A. Socinski [États-Unis] ; Coleman K. Obasaju [États-Unis] | Exploratory Subset Analysis of African Americans From the PointBreak Study: Pemetrexed-Carboplatin-Bevacizumab Followed by Maintenance Pemetrexed-Bevacizumab Versus Paclitaxel-Carboplatin-Bevacizumab Followed by Maintenance Bevacizumab in Patients With Stage IIIB/IV Nonsquamous Non-Small-Cell Lung Cancer. |
| 000C05 (2014) |
Aju Mathew [États-Unis] ; Adam M. Brufsky [États-Unis] | The use of adjuvant bisphophonates in the treatment of early-stage breast cancer. |
| 000F89 (2014) |
Charles Butts [Canada] ; Mark A. Socinski [États-Unis] ; Paul L. Mitchell [Australie] ; Nick Thatcher [Royaume-Uni] ; Libor Havel [République tchèque] ; Maciej Krzakowski [Pologne] ; Sergiusz Nawrocki [Pologne] ; Tudor-Eliade Ciuleanu [Roumanie] ; Lionel Bosquée [Belgique] ; José Manuel Trigo [Espagne] ; Alexander Spira [États-Unis] ; Lise Tremblay [Canada] ; Jan Nyman [Suède] ; Rodryg Ramlau [Pologne] ; Gun Wickart-Johansson [Suède] ; Peter Ellis [Canada] ; Oleg Gladkov [Russie] ; José Rodrigues Pereira [Brésil] ; Wilfried Ernst Erich Eberhardt [Allemagne] ; Christoph Helwig [Allemagne] ; Andreas Schröder [Allemagne] ; Frances A. Shepherd [Canada] | Tecemotide (L-BLP25) versus placebo after chemoradiotherapy for stage III non-small-cell lung cancer (START): a randomised, double-blind, phase 3 trial. |
| 001073 (2014) |
Michael Leonard Friedlander [États-Unis] ; Martin Stockler ; Rachel O'Connell ; Merryn Voysey ; Amit Oza ; Kim Gillies ; Heidi Donovan ; Julie Martyn ; Katrin Sjoquist ; Phyllis Butow ; Madeleine T. King | Symptom burden and outcomes of patients with platinum resistant/refractory recurrent ovarian cancer: a reality check: results of stage 1 of the gynecologic cancer intergroup symptom benefit study. |
| 001291 (2014) |
José Pablo Leone [États-Unis] ; Julieta Leone ; Carlos Teodoro Vallejo ; Juan Eduardo Pérez ; Alberto Omar Romero ; Mario Raul Machiavelli ; Luis Romero Acu A ; María Ester Domínguez ; Mario Langui ; Hebe Margot Fasce ; Bernardo Amadeo Leone ; Eduardo Ortiz ; Julián Iturbe ; Ariel Osvaldo Zwenger | Sixteen years follow-up results of a randomized phase II trial of neoadjuvant fluorouracil, doxorubicin, and cyclophosphamide (FAC) compared with cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) in stage III breast cancer: GOCS experience. |
| 001924 (2014) |
Lakhmir S. Chawla [États-Unis] ; Charles A. Herzog [États-Unis] ; Maria Rosa Costanzo [États-Unis] ; James Tumlin [États-Unis] ; John A. Kellum [États-Unis] ; Peter A. Mccullough [États-Unis] ; Claudio Ronco [Italie] | Proposal for a functional classification system of heart failure in patients with end-stage renal disease: proceedings of the acute dialysis quality initiative (ADQI) XI workgroup. |
| 002609 (2014) |
Ann M. O'Hare [États-Unis] ; John R. Hotchkiss [États-Unis] ; Manjula Kurella Tamura [États-Unis] ; Eric B. Larson [États-Unis] ; Brenda R. Hemmelgarn [Canada] ; Adam Batten [États-Unis] ; Thy P. Do [États-Unis] ; Kenneth E. Covinsky [États-Unis] | Interpreting treatment effects from clinical trials in the context of real-world risk information: end-stage renal disease prevention in older adults. |
| 002670 (2014) |
Joel L. Weissfeld [États-Unis] ; Brenda Diergaarde ; Tomoko Nukui ; Shama Buch ; Arjun Pennathur ; Mark A. Socinski ; Jill M. Siegfried ; Marjorie Romkes | Inherited variation in the ATP-binding cassette transporter ABCB1 and survival after chemotherapy for stage III-IV lung cancer. |
| 002F10 (2014) |
Gaurav Goel [États-Unis] | Evolving role of gene expression signatures as biomarkers in early-stage colon cancer. |
| 002F67 (2014) |
R N Lown [Royaume-Uni] ; S G E. Marsh [Royaume-Uni] ; G E Switzer [États-Unis] ; K A Latham [Royaume-Uni] ; J A Madrigal [Royaume-Uni] ; B E Shaw [Royaume-Uni] | Ethnicity, length of time on the register and sex predict donor availability at the confirmatory typing stage. |
| 003041 (2014) |
Mark B. Zimering [États-Unis] ; Jane H. Zhang [États-Unis] ; Peter D. Guarino [États-Unis] ; Nicholas Emanuele [États-Unis] ; Peter A. Mccullough [États-Unis] ; Linda F. Fried [États-Unis] | Endothelial Cell Autoantibodies in Predicting Declining Renal Function, End-Stage Renal Disease, or Death in Adult Type 2 Diabetic Nephropathy |
| 003181 (2014) |
Takeshi Osonoi [Japon] ; Miyoko Saito [Japon] ; Atsuko Tamasawa [Japon] ; Hidenori Ishida [Japon] ; Daisuke Tsujino [Japon] ; Rimei Nishimura [Japon, États-Unis] ; Kazunori Utsunomiya [Japon] | Effect of Hemodialysis on Plasma Glucose Profile and Plasma Level of Liraglutide in Patients with Type 2 Diabetes Mellitus and End-Stage Renal Disease: A Pilot Study |
| 003185 (2014) |
Viswanath Aluru [États-Unis] ; Ying Lu [États-Unis] ; Alan Leung [États-Unis] ; Joe Verghese [États-Unis] ; Preeti Raghavan [États-Unis] | Effect of Auditory Constraints on Motor Performance Depends on Stage of Recovery Post-Stroke |
| 003187 (2014) |
Hans-Joachim Schmoll ; Chris Twelves ; Weijing Sun ; Michael J. O'Connell ; Thomas Cartwright ; Edward Mckenna ; Muhammad Saif ; Steve Lee ; Greg Yothers ; Daniel Haller | Effect of Adjuvant Capecitabine or Fluorouracil, with or without Oxaliplatin, on Survival Outcomes in Stage III Colon Cancer and the Effect of Oxaliplatin on Post-Relapse Survival: A Pooled Analysis of Individual Patient Data from Four Randomised Controlled Trials |
| 003274 (2014) |
Alan R. Catanzariti [États-Unis] ; Adebola T. Adeleke [États-Unis] | Double arthrodesis through a medial approach for end-stage adult-acquired flatfoot. |
| 003577 (2014) |
Zhongren Zhou [États-Unis] ; Santhoshi Bandla [États-Unis] ; Jiqing Ye [États-Unis] ; Yinglin Xia [États-Unis] ; Jianwen Que [États-Unis] ; James D. Luketich [États-Unis] ; Arjun Pennathur [États-Unis] ; Jeffrey H. Peters [États-Unis] ; Dongfeng Tan [États-Unis] ; Tony E. Godfrey [États-Unis] | Cyclin E involved in early stage carcinogenesis of esophageal adenocarcinoma by SNP DNA microarray and immunohistochemical studies |
| 003626 (2014) |
Amy Soni [États-Unis] ; Sherrie L. Aspinall ; Xinhua Zhao ; Chester B. Good ; Francesca E. Cunningham ; Gurkamal Chatta ; Vida Passero ; Kenneth J. Smith | Cost-Effectiveness Analysis of Adjuvant Stage III Colon Cancer Treatment at Veterans Affairs Medical Centers. |
| 003783 (2014) |
Keri N. Althoff [États-Unis] ; Kathleen A. Mcginnis ; Christina M. Wyatt [États-Unis] ; Matthew S. Freiberg [États-Unis] ; Cynthia Gilbert ; Krisann K. Oursler ; David Rimland ; Maria C. Rodriguez-Barradas [États-Unis] ; Robert Dubrow [États-Unis] ; Lesley S. Park [États-Unis] ; Melissa Skanderson [États-Unis] ; Meredith S. Shiels [États-Unis] ; Stephen J. Gange [États-Unis] ; Kelly A. Gebo [États-Unis] ; Amy C. Justice [États-Unis] | Comparison of Risk and Age at Diagnosis of Myocardial Infarction, End-Stage Renal Disease, and Non-AIDS-Defining Cancer in HIV-Infected Versus Uninfected Adults |
| 003E32 (2014) |
Theresa A. Koleck ; Catherine M. Bender ; Susan M. Sereika ; Gretchen Ahrendt ; Rachel C. Jankowitz ; Kandace P. Mcguire ; Christopher M. Ryan ; Yvette P. Conley | Apolipoprotein E genotype and cognitive function in postmenopausal women with early-stage breast cancer. |
